133 Startups
  • Sector
  • Participated in
  • Year of participation

Autoscriber

  • 2022
  • Enabling Technology
  • Venture Challenge
Autoscriber offers a software solution that aims to save the physician 30% of their time they spend on administration while more accurately extracting all the important information. This is done by listening in on the doctor-patient consultation and transcribing this using Speech-to-Text models.

Avalanche Medical

  • 2018
  • Medical Device
  • Venture Challenge
Provide pain relief and functional restoration for patients suffering from focal knee cartilage defects, which is a chronic and severely disabling musculoskeletal condition.

Beephonix

  • 2022
  • Medical Device
  • Venture Challenge
Beephonix develops a biomimetic microphones to improve hearing in noisy conditions. The approach mimics the way bees move their antennae.

BI/OND

  • 2016
  • Enabling Technology
  • Venture Challenge
The hardware of choice for OCC in-vitro testing of drug candidates, reducing the incidence of false positives and false negative in pre-clinical trials.

BIMINI Biotech

  • 2019
  • Therapeutics
  • Venture Challenge
BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing.

Biomimiq

  • Enabling Technology
  • Venture Challenge
Biomimiq provides both healthy and diseased in vitro human skin equivalent for animal free compound screening and safety testing services

Breathomix

  • 2015
  • Diagnostics
  • Venture Challenge
The goal of Breathomix is to bring exhaled breath based diagnosis to medicine in a point of care setting.

CC Diagnostics

  • 2017
  • Diagnostics
  • Venture Challenge
CC Diagnostics offers a superior, easily implementable triage test with an unsurpassed specificity and reproducibility, which will decrease the number of misdiagnosed women, decrease healthcare costs, and increase screening participation.

Cell4Pharma

  • 2011
  • Enabling Technology
  • Venture Challenge
ciPTEC is a human renal cell line that mimics the proximal tubule cells of the kidney. These cells are a main target for drug-induced kidney injury, caused by their role in highly efficient transport of drugs and toxic compounds from the bloodstream into urine. The most relevant drug transporter proteins involved in this process are stably and functionally expressed in our cell models.

Cenya Imaging

  • 2015
  • Diagnostics
  • Enabling Technology
Cenya Imaging is a clinical stage company developing medical imaging agents to track cells in patients and measure the biodistribution and pharmacokinetics of cell therapies.